Bluetongue virus and double-stranded RNA increase human vascular permeability: Role of p38 MAPK

Journal of Clinical Immunology

Volumn 26, Issue 4, 2006, Pages 406-416

  Chiang, Eddie T ^b   Persaud Sawin, Dixie Ann ^a   Kulkarni, Sandhya ^a   Garcia, Joe G N ^b   Imani, Farhad ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bluetongue virus; Double stranded RNA (dsRNA); Hemorrhagic fever; MAP kinase; Vascular permeability

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; CYTOKINE; DOUBLE STRANDED RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULAR TARGETING AGENT;

ARTICLE; BLEEDING DISORDER; BLOOD VESSEL PERMEABILITY; BLUETONGUE ORBIVIRUS; BOVIDS; CONTROLLED STUDY; DOSE RESPONSE; ELECTRIC RESISTANCE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM LESION; ENZYME INHIBITION; GENE INDUCTION; HEMORRHAGIC FEVER; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; LUNG INFECTION; PRIORITY JOURNAL; VIRUS INFECTION;

BLUETONGUE VIRUS; CAPILLARY PERMEABILITY; CELLS, CULTURED; CYTOKINES; CYTOSKELETON; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HEMORRHAGIC FEVERS, VIRAL; HUMANS; LUNG; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA, DOUBLE-STRANDED;

EID: 33745914638     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9024-4     Document Type: Article

References (72)

1. Theiler M, Smith HH: The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65, 787-800 (1937).
2. Rev Med Virol 10: 6-16; discussion 13-15, 2000.
3. Hensley LE, Young HA, Jahrling PB, Geisbert TW: Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80:169-179, 2002.
4. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E: Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:163-168, 2002.
5. Bram RA, George JE, Reichar RE, Tabaciinic WJ: Threat of foreign arthropod-borne pathogens to livestock in the United States. J Med Entomol 39:405-416, 2002.
6. MacLachlan NJ: The pathogenesis and immunology of bluetongue virus infection of ruminants. Comp Immunol Microbiol Infect Dis 17:197-206, 1994.
7. Coen ML, Ellis JA, O'Toole DT, Wilson WC: Cytokine modulation of the interaction between bluetongue virus and endothelial cells in vitro. Vet Pathol 28:524-532, 1991.
8. DeMaula CD, Leutenegger CM, Jutila MA, MacLachlan NJ: Bluetongue virus-induced activation of primary bovine lung microvascular endothelial cells. Vet Immunol Immunopathol 86:147-157, 2002.
9. Jacobs BL, Langland JO: When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349, 1996.
10. Koliais SI: Presence of double stranded regions of viral RNA in infected cells. Experientia 37:971-972, 1981.
11. Lee JY, Marshall JA, Bowden DS: Characterization of rubella virus replication complexes using antibodies to double-stranded RNA. Virology 200:307-312, 1994.
12. Mackenzie JM, Jones MK, Young PR: Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220:232-240, 1996.
13. Majde JA, Guha-Thakurta N, Chen Z, Bredow S, Krueger JM: Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: Implications for the viral acute phase response. Arch Virol 143:2371-2380, 1998.
14. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P: The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97:12289-12294, 2000.
15. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ: Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms [published erratum appears in Science 1995 Jul 7;269(5220):17. Science 267:682-685, 1995.
16. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811, 1994.
17. Hashimoto S, Matsumoto K, Gon Y, Maruoka S, Kujime K, Hayashi S, Takeshita I, Horie T: p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells [see comments]. Clin Exp Allergy 30:48-55, 2000.
18. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ: MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16:1247-1255, 1996.
19. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH: MAP kinases. Chem Rev 101:2449-2476, 2001.
20. Fearns C, Kline L, Gram H, Di Padova F, Zurini M, Han J, Ulevitch RJ: Coordinate activation of endogenous p38alpha, beta, gamma, and delta by inflammatory stimuli. J Leukoc Biol 67:705-711, 2000.
21. Hale KK, Trollinger D, Rihanek M, Manthey CL: Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 162:4246-4252, 1999.
22. Hedges JC, Singer CA, Gerthoffer WT: Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Am J Respir Cell Mol Biol 23:86-94, 2000.
23. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746, 1994.
24. Meusel TR, Imani F: Viral Induction of Inflammatory Cytokines in Human Epithelial Cells Follows a p38 Mitogen-Activated Protein Kinase-Dependent but NF-kappaB-Independent Pathway. J Immunol 171:3768-3774, 2003.
25. Borbiev T, Verin AD, Birukova A, Liu F, Crow MT, Garcia JG: Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 285:L43-54, 2003.
26. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, 2nd, Duran WN: VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284:H92-H100, 2003.
27. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV: Modulation of endotoxin-induced endothelial activity by microtubule depolymerization. J Trauma 54:104-112; discussion 112-103, 2003.
28. Garcia JG, Wang P, Schaphorst KL, Becker PM, Borbiev T, Liu F, Birukova A, Jacobs K, Bogatcheva N, Verin AD: Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. Faseb J 16:1064-1076, 2002.
29. Parinandi NL, Kleinberg MA, Usatyuk PV, Cummings RJ, Pennathur A, Cardounel AJ, Zweier JL, Garcia JG, Natarajan V: Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 284:L26-38, 2003.
30. Pedram A, Razandi M, Levin ER: Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273:26722-26728, 1998.
31. Verin AD, Liu F, Bogatcheva N, Borbiev T, Hershenson MB, Wang P, Garcia JG: Role of ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 279:L360-370, 2000.
32. Garrington TP, Johnson GL: Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11:211-218, 1999.
33. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869, 2001.
34. Brinkman BM, Telliez JB, Schievella AR, Lin LL, Goldfeld AE: Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2- and p38 mitogen-activated protein kinase-dependent TNF-alpha gene expression. J Biol Chem 274:30882-30886, 1999.
35. Enslen H, Tokumitsu H, Stork PJ, Davis RJ, Soderling TR: Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. Proc Natl Acad Sci U S A 93:10803-10808, 1996.
36. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J, Enslen H, Tokumitsu H, Stork PJ, Davis RJ, Soderling TR: Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2 Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. J Biol Chem 273:31327-31336, 1998.
37. Garcia JG, Verin AD, Schaphorst K, Siddiqui R, Patterson CE, Csortos C, Natarajan V: Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am J Physiol 276:L989-998, 1999.
38. Borbiev T, Verin AD, Shi S, Liu F, Garcia JG: Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol 280:L983-990, 2001.
39. Garcia JG, Schaphorst KL, Verin AD, Vepa S, Patterson CE, Natarajan V: Diperoxovanadate alters endothelial cell focal contacts and barrier function: Role of tyrosine phosphorylation. J Appl Physiol 89:2333-2343, 2000.
40. Liu F, Verin AD, Borbiev T, Garcia JG: Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. Am J Physiol - Lung Cell Mol Physiol 280:L1309-1317, 2001.
41. Tiruppathi C, Brandsch M, Miyamoto Y, Ganapathy V, Leibach FH: Constitutive expression of the taurine transporter in a human colon carcinoma cell line. Am J Physiol 263:G625-631, 1992.
42. Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, Jahrling PB: Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 179 Suppl 1:S203-217, 1999.
43. Lukashevich IS, Maryankova R, Vladyko AS, Nashkevich N, Koleda S, Djavani M, Horejsh D, Voitenok NN, Salvato MS: Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL-8 and TNF-alpha gene expression. J Med Virol 59:552-560, 1999.
44. MacLachlan NJ, Conley AJ, Kennedy PC: Bluetongue and equine viral arteritis viruses as models of virus-induced fetal injury and abortion. Anim Reprod Sci 60-61:643-651, 2000.
45. Doukas J, Cutler AH, Mordes JP: Polyinosinic: Polycytidylic acid is a potent activator of endothelial cells. Am J Pathol 145:137-147, 1994.
46. Goh KC, de Veer MJ, Williams BR: The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin [In Process Citation]. Embo J 19:4292-4297, 2000.
47. Harcourt JL, Offermann MK: Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells. Eur J Biochem 267:2768-2777, 2000.
48. Kehoe KE, Brown MA, Imani F: Double-stranded RNA regulates IL-4 expression. J Immunol 167:2496-2501, 2001.
49. Krueger JM, Majde JA: Microbial products and cytokines in sleep and fever regulation. Crit Rev Immunol 14:355-379, 1994.
50. Lebre MC, Antons JC, Kalinski P, Schuitemaker JH, van Capel TM, Kapsenberg ML, De Jong EC: Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarized phenotype in dendritic cells: role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18. J Invest Dermatol 120:990-997, 2003.
51. Marcus PI: The interferon inducer moiety of viruses: A single molecule of dsRNA. Tex Rep Biol Med 41:70-75, 1981.
52. Meusel TR, Kehoe KE, Imani F: Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J Immunol 168:6429-6435, 2002.
53. Bamforth SD, Lightman S, Greenwood J: The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo. Acta Neuropathol (Berl) 91:624-632, 1996.
54. Desai TR, Leeper NJ, Hynes KL, Gewertz BL: Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 104:118-123, 2002.
55. Marcus BC, Wyble CW, Hynes KL, Gewertz BL: Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression. Surgery 120:411-416; discussion 416-417, 1996.
56. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD: The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 28:574-581, 2003.
57. Vadeboncoeur N, Segura M, Al-Numani D, Vanier G, Gottschalk M: Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol Med Microbiol 35:49-58, 2003.
58. Banan A, Fields JZ, Zhang Y, Keshavarzian A: iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 280:G1234-1246, 2001.
59. Dudek SM, Garcia JG: Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91:1487-1500, 2001.
60. Lee TY, Gotlieb AI: Microfilaments and microtubules maintain endothelial integrity. Microsc Res Tech 60:115-127, 2003.
61. Nag S: Role of the endothelial cytoskeleton in blood-brain-barrier permeability to protein. Acta Neuropathol (Berl) 90:454-460, 1995.
62. Richard JF, Petit L, Gibert M, Marvaud JC, Bouchaud C, Popoff MR: Bacterial toxins modifying the actin cytoskeleton. Int Microbiol 2:185-194, 1999.
63. Kikuchi K, Yanagawa Y, Aranami T, Iwabuchi C, Iwabuchi K, Onoe K: Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation. Immunology 108:42-49, 2003.
64. Kips JC, Tavernier JH, Joos GF, Peleman RA, Pauwels RA: The potential role of tumour necrosis factor alpha in asthma. Clin Exp Allergy 23:247-250, 1993.
65. Krunkosky TM, Fischer BM, Martin LD, Jones N, Akley NJ, Adler KB: Effects of TNF-alpha on expression of ICAM-1 in human airway epithelial cells in vitro. Signaling pathways controlling surface and gene expression. Am J Respir Cell Mol Biol 22:685-692, 2000.
66. O'Shea JJ, Ma A, Lipsky P: Cytokines and autoimmunity. Nat Rev Immunol 2:37-45, 2002.
67. Baetu TM, Hiscott J: On the TRAIL to apoptosis. Cytokine Growth Factor Rev 13:199-207, 2002.
68. Benedict CA, Banks TA, Ware CF: Death and survival: Viral regulation of TNF signaling pathways. Curr Opin Immunol 15:59-65, 2003.
69. Boehme MW, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP: Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: In vivo and in vitro studies. Immunology 87:134-140, 1996.
70. Camera M, Giesen PL, Fallon J, Aufiero BM, Taubman M, Tremoli E, Nemerson Y: Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vase Biol 19:531-537, 1999.
71. DeMaula CD, Jutila MA, Wilson DW, MacLachlan NJ: Infection kinetics, prostacyclin release and cytokine-mediated modulation of the mechanism of cell death during bluetongue virus infection of cultured ovine and bovine pulmonary artery and lung microvascular endothelial cells. J Gen Virol 82:787-794, 2001.
72. Mortola E, Noad R, Roy P: Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J Virol 78:2875-2883, 2004.